yohimbane has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Jiang, J; Jiao, Y; Shao, J; Tang, D; Wang, Z; Xu, S; Yin, W; Yu, W; Zhang, Y; Zhou, W | 1 |
1 other study(ies) available for yohimbane and Disease Models, Animal
| Article | Year |
|---|---|
Dexmedetomidine maintains blood-brain barrier integrity by inhibiting Drp1-related endothelial mitochondrial dysfunction in ischemic stroke.
Topics: Adenylate Kinase; Adrenergic alpha-2 Receptor Antagonists; Animals; Blood-Brain Barrier; Cell Line; Cytokines; Dexmedetomidine; Disease Models, Animal; Dynamins; Endothelial Cells; Glial Fibrillary Acidic Protein; Humans; Indole Alkaloids; Infarction, Middle Cerebral Artery; Ischemic Stroke; Male; Mitochondria; Mitochondrial Dynamics; Neuroprotective Agents; Phosphorylation; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2021 |